Real World Prostate Cancer Registry

To determine practice patterns for prostate cancer in the region.

Prostate cancer is the most common cancer diagnosed in men in the USA with 268,490 cases
 diagnosed in 2022 constituting 27% of male cancers and 34,500 deaths (11%) occurred in same
 year.1 Prostate cancer is a very heterogeneous disease that has different presentations,
 molecular and pathological features, stages, and disease biology. The treatment options are
 dependent on the disease stage, its features, and the patient's condition and preferences.
 The disease outcome also varies significantly due to the previous heterogeneity of the
 features in addition to other social determinants of health.
 
 Therefore, it is critical to obtain real-world data that reflects the actual patterns of
 prostate cancer presentation, work up, management, and outcome. Real World Prostate Cancer
 Registry (RWPCR) aims at compiling real world data from patients presented with prostate
 cancer in the tristate area. The data collection will be prospective and longitudinal
 including patients' demographics and disease characteristics, work up, management, and
 outcome.